TransDigm, HEICO, & the Aircraft & Parts Lifecycle
Former Director at Transdigm and Current at PMA Shop
inpractise.com/articles/heico-in-prog
Former Director at Transdigm and Current at PMA Shop
Interview Transcript
This is a snippet of the transcript, sign up to read more.
How much of this approach is driven by Nick Howley, or is it now more driven by Kevin and the team currently running the company?
(At TransDigm) Decisions are made in a decentralized fashion at the place closest to creating value, right next to the customer. Those things are important.
This is a snippet of the transcript, sign up to read more.
So, you're saying that even after five years of that 10-year period, that's when these things start to come in, other than the OEMs. If you have Boeing Global Care, then after 15 years, these things start to kick in, basically.
In most cases. There are certain systems and components where the transition can happen sooner, and others where it never happens. The point is, how do you choose the products you provide? If you're the OEM, you want to pick the product where the transition never happens. So, if you have a larger quantity of things where it doesn't matter, Boeing Care is gone, and everything else is too high a risk from the airline operator's or leasing company's perspective to even entertain a third party, you want more of those products than the ones deemed low risk.
This is a snippet of the transcript, sign up to read more.
So, I'm curious about the pricing at the onset of a program. What is the IRR like? You have to project it for almost 30 to 35 years of cash flow? That's 15 years of warranty, and then the price you're going to get afterward. What is the typical IRR that component makers aim to achieve?
They (parts manufacturers) aim for a 20% return, but do they achieve it all the time? Probably not. I would estimate their returns to be between 15% and 30% IRR, considering the capital tied up in designing and developing these products. If the returns were lower, it might not make sense to invest in this area. As capital investors, you would be better suited to assess that.
This is a snippet of the transcript, sign up to read more.
Related Content
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.